Antibacterial microcins, class II: A review
- 1 June 2023
- journal article
- review article
- Published by ECO-Vector LLC in Epidemiology and Infectious Diseases
- Vol. 28 (2) , 98-109
Abstract
In medicine, the issue of the use of effective antibacterial substances against drug-resistant microorganisms remains relevant. Most publications on microcins show undoubted prospects for the further development of these pharmacological agents of bacterial origin with multidirectional action (antibacterial, antiviral, antitumor, etc.). One of the features of microcins is their specific inhibitory activity against gram-negative microorganisms (Escherichia, Proteus, Salmonella, Pseudomonas, etc.). This review aimed to briefly summarize current information about one of the groups of microcins (class II) to assess their possible use in practical medicine and scientific research. The review uses sources from the Russian Science Citation Index, Web of Science, Scopus, and PubMed databases.Keywords
This publication has 44 references indexed in Scilit:
- Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclatureNatural Product Reports, 2012
- Antimicrobial Peptides for Therapeutic Applications: A ReviewMolecules, 2012
- Identification and Characterization of Microcin S, a New Antibacterial Peptide Produced by Probiotic Escherichia coli G3/10PLOS ONE, 2012
- Mechanism of Bactericidal Activity of Microcin L inEscherichia coliandSalmonella entericaAntimicrobial Agents and Chemotherapy, 2011
- Isolation and Characterization of Two Members of the Siderophore-Microcin Family, Microcins M and H47Antimicrobial Agents and Chemotherapy, 2010
- Modular Structure of Microcin H47 and Colicin VAntimicrobial Agents and Chemotherapy, 2007
- Comparative Analysis of Chromosome-Encoded MicrocinsAntimicrobial Agents and Chemotherapy, 2006
- Genetic Analysis and Complete Primary Structure of Microcin LAntimicrobial Agents and Chemotherapy, 2004
- Wild-type Escherichia coli producing microcins B17, D93, J25, and L; cloning of genes for microcin L production and immunityCanadian Journal of Microbiology, 2003
- The Proton Channel Is the Minimal Structure of ATP Synthase Necessary and Sufficient for Microcin H47 Antibiotic ActionAntimicrobial Agents and Chemotherapy, 2003